Cynomolgus prostate specific antigen

Details for Australian Patent Application No. 2005249450 (hide)

Owner Centocor, Inc.

Inventors Snyder, Linda A.; Marshall, Deborah J.

Agent Shelston IP

Pub. Number AU-A-2005249450

PCT Pub. Number WO2005/117964

Priority 60/575,079 27.05.04 US

Filing date 26 May 2005

Wipo publication date 15 December 2005

International Classifications

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

A61K 39/385 (2006.01) Medicinal preparations containing antigens or antibodies - Haptens or antigens, bound to carriers

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 14/82 (2006.01) Peptides having more than 20 amino acids - Translation products from oncogenes

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

21 December 2006 PCT application entered the National Phase

  PCT publication WO2005/117964 Priority application(s): WO2005/117964

22 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005249453-A surgical device for capturing, positioning and aligning portions of a severed human sternum

2005249446-Biomarkers for monitoring inhibition of IMPDH pathway